Atlas Trials

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Clinical trial NCT00835354 · COMPLETED

Trial details

NCT number
NCT00835354
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-05-01
Primary completion
2004-05-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.